Corticosteroid-induced osteoporosis.
The pathophysiology of corticosteroid-induced osteoporosis is outlined in this article. Treatment options, based upon our understanding of the pathophysiology, and a review of the available literature are offered.
Adachi
J D
JD
Department of Medicine, St. Joseph's Hospital--McMaster University, Ontario, Canada.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D045930:Anabolic Agents / Q000627:therapeutic use; D001846:Bone Development; D001862:Bone Resorption / Q000517:prevention & control; D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008954:Models, Biological; D010024:Osteoporosis / Q000139:chemically induced* / Q000503:physiopathology* / Q000517:prevention & control; D012969:Sodium Fluoride / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D045930:Anabolic Agents; D004164:Diphosphonates; D004967:Estrogens; D014807:Vitamin D; D012969:Sodium Fluoride; D002116:Calcitonin